Gilder Gagnon Howe & Co’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
|
|||||
|
2025
Q1 | $704K | Buy |
|
|||||
|
2024
Q4 | $1.02M | Buy |
|
|||||
|
2024
Q3 | $1.12M | Buy |
|
|||||
|
2024
Q2 | $1.2M | Sell |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $327K | Sell |
|
|||||
|
2023
Q3 | $245K | Buy |
|
|||||
|
2023
Q2 | $543K | Sell |
|
|||||
|
2023
Q1 | $433K | Buy |
|
|||||
|
2022
Q4 | $209K | Sell |
|
|||||
|
2022
Q3 | $743K | Sell |
|
|||||
|
2022
Q2 | $770K | Sell |
|
|||||
|
2022
Q1 | $11.9M | Sell |
|
|||||
|
2021
Q4 | $25.7M | Sell |
|
|||||
|
2021
Q3 | $28.6M | Sell |
|
|||||
|
2021
Q2 | $41.9M | Sell |
|
|||||
|
2021
Q1 | $49.2M | Sell |
|
|||||
|
2020
Q4 | $91.1M | Sell |
|
|||||
|
2020
Q3 | $49.9M | Sell |
|
|||||
|
2020
Q2 | $37.4M | Sell |
|
|||||
|
2020
Q1 | $38.6M | Sell |
|
|||||
|
2019
Q4 | $51.7M | Sell |
|
|||||
|
2019
Q3 | $40.3M | Buy |
|
|||||
|
2019
Q2 | $54.3M | Buy |
|